BDBM50008376 2-[2-(2-{2-[2-(2-{6-Amino-2-[2-amino-3-(3H-imidazol-4-yl)-propionylamino]-hexanoylamino}-3-carboxy-propionylamino)-4-methylsulfanyl-butyrylamino]-4-carbamoyl-butyrylamino}-4-methyl-pentanoylamino)-acetylamino]-5-guanidino-pentanoic acid(His-Lys-Asp-Met-Gln-Leu-Gly-Arg)::CHEMBL61726::H-His-Lys-AspMet-GIn-Leu-Gly-Arg-OH
SMILES: CSCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
InChI Key: InChIKey=FMOGCXPDTJCTRH-BMGWUDNWSA-N
Data: 2 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C5a anaphylatoxin chemotactic receptor (C5aR) (Homo sapiens (Human)) | BDBM50008376 (2-[2-(2-{2-[2-(2-{6-Amino-2-[2-amino-3-(3H-imidazo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | 3.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories Curated by ChEMBL | Assay Description Inhibition of [125I]-C5a binding to C5a anaphylatoxin chemotactic receptor in PMNL membranes | J Med Chem 34: 2068-71 (1991) BindingDB Entry DOI: 10.7270/Q21Z43C8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
C5a anaphylatoxin chemotactic receptor (C5aR) (Homo sapiens (Human)) | BDBM50008376 (2-[2-(2-{2-[2-(2-{6-Amino-2-[2-amino-3-(3H-imidazo...) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL KEGG PC cid PC sid UniChem Similars | PubMed | 3.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories Curated by ChEMBL | Assay Description Inhibitory activity against [125I]-rC5a binding to C5a anaphylatoxin chemotactic receptor in human polymorphonuclear leukocyte (PMNL) membranes | J Med Chem 35: 402-6 (1992) BindingDB Entry DOI: 10.7270/Q2HH6J1S | |||||||||||
More data for this Ligand-Target Pair |